Ania M. Jastreboff

Tirzepatide Once Weekly for the Treatment of Obesity

Ania M. Jastreboff, Louis J. Aronne, Nadia N. Ahmad et al. · New England Journal of Medicine · 2022 · 3.2K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity

W. Timothy Garvey, Jeffrey I. Mechanick, Elise M. Brett et al. · Endocrine Practice · 2016 · 1.8K citations

Medicine, Endocrinology, Internal Medicine +15

Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

Ania M. Jastreboff, Lee M. Kaplan, Juan P. Frías et al. · New England Journal of Medicine · 2023 · 966 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Obesity as a Disease: The Obesity Society 2018 Position Statement

Ania M. Jastreboff, Catherine M. Kotz, Scott Kahan et al. · Obesity · 2018 · 448 citations · Full text

Medicine, Endocrinology, Physiology +15

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

Julio Rosenstock, Juan P. Frías, Ania M. Jastreboff et al. · The Lancet · 2023 · 376 citations

Medicine, Endocrinology, Pharmacology +14